Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib

Title
Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib
Authors
Keywords
NSCLC, T790M, BRAF, V600E, Acquired resistance, Targeted therapy
Journal
Journal of Thoracic Oncology
Volume 12, Issue 3, Pages 567-572
Publisher
Elsevier BV
Online
2016-12-05
DOI
10.1016/j.jtho.2016.11.2231

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now